Isatuximab Plus Carfilzomib and Dexamethasone in Relapsed Multiple Myeloma: Ikema Subgroup Analysis By Number of Prior Lines of Treatment
- Resource Type
- Abstract
- Source
- In
Blood 15 November 2022 140 Supplement 1:7138-7140 - Subject
- Language
- ISSN
- 0006-4971